Tag: basalBreastCancer

Basal or basal-like breast cancer: Most often triple negative (ER-/PR-/HER2-) breast cancer. However, not all basal tumors are triple negative and not all triple negative tumors are basal.

Articles

News

11/29/13: Vitamin D favorably influences breast cancer-related genes
08/01/11: BC subtype influences prognosis after neoadjuvant chemotherapy

Studies

Molecular subtypes of breast cancer predicting clinical benefits of radiotherapy after breast-conserving surgery: a propensity-score-matched cohort study Cite
Hung S, Yang H, Lee M, Liu D, Chen L, Chew C, et al. Molecular subtypes of breast cancer predicting clinical benefits of radiotherapy after breast-conserving surgery: a propensity-score-matched cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2023; 25 10.1186/s13058-023-01747-9
Intrinsic Subtypes and Androgen Receptor Gene Expression in Primary Breast Cancer. A Meta-Analysis Cite
Cruz-Tapias P, Rubiano W, Rondón-Lagos M, Villegas V, Rangel N. Intrinsic Subtypes and Androgen Receptor Gene Expression in Primary Breast Cancer. A Meta-Analysis. Biology. MDPI AG; 2021; 10:834 10.3390/biology10090834
AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program Cite
Wu X, Li X, Fu Q, Cao Q, Chen X, Wang M, et al. AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program. Journal of Experimental Medicine. Rockefeller University Press; 2017; 214:1065-1079 10.1084/jem.20160903
Abstract PD8-03: Differences in the mutational landscape in African Americans and Caucasians with triple negative breast cancer Cite
Ademuyiwa F, Tao Y, Luo J. Abstract PD8-03: Differences in the mutational landscape in African Americans and Caucasians with triple negative breast cancer. Poster Discussion Abstracts. American Association for Cancer Research; 2017; 10.1158/1538-7445.sabcs16-pd8-03
p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors Cite
Chiche A, Moumen M, Romagnoli M, Petit V, Lasla H, Jézéquel P, et al. p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors. Oncogene. Springer Science and Business Media LLC; 2016; 36:2355-2365 10.1038/onc.2016.396
Height and Body Size in Childhood, Adolescence, and Young Adulthood and Breast Cancer Risk According to Molecular Subtype in the Nurses' Health Studies Cite
Warner ET, Hu R, Collins LC, Beck AH, Schnitt S, Rosner B, et al. Height and Body Size in Childhood, Adolescence, and Young Adulthood and Breast Cancer Risk According to Molecular Subtype in the Nurses' Health Studies. Cancer Prevention Research. American Association for Cancer Research (AACR); 2016; 9:732-738 10.1158/1940-6207.capr-16-0085
Obesity-Associated Alterations in Inflammation, Epigenetics, and Mammary Tumor Growth Persist in Formerly Obese Mice Cite
Rossi EL, de Angel RE, Bowers LW, Khatib SA, Smith LA, Van Buren E, et al. Obesity-Associated Alterations in Inflammation, Epigenetics, and Mammary Tumor Growth Persist in Formerly Obese Mice. Cancer Prevention Research. American Association for Cancer Research (AACR); 2016; 9:339-348 10.1158/1940-6207.capr-15-0348
Abstract 4536: Polyunsaturated fatty acids alter the epigenetic landscape in triple-negative breast cancer (TNBC) Cite
Chattin AM, O’Brien M, Pardini RS. Abstract 4536: Polyunsaturated fatty acids alter the epigenetic landscape in triple-negative breast cancer (TNBC). Molecular and Cellular Biology, Genetics. American Association for Cancer Research; 2016; 10.1158/1538-7445.am2016-4536
Weight loss reduces basal-like breast cancer through kinome reprogramming Cite
Qin Y, Sundaram S, Essaid L, Chen X, Miller SM, Yan F, et al. Weight loss reduces basal-like breast cancer through kinome reprogramming. Cancer Cell International. Springer Science and Business Media LLC; 2016; 16 10.1186/s12935-016-0300-y
Post-diagnosis adiposity and survival among breast cancer patients: influence of breast cancer subtype Cite
Sun X, Nichols HB, Robinson W, Sherman ME, Olshan AF, Troester MA. Post-diagnosis adiposity and survival among breast cancer patients: influence of breast cancer subtype. Cancer Causes & Control. Springer Science and Business Media LLC; 2015; 26:1803-1811 10.1007/s10552-015-0673-6
Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence Cite
Keenan T, Moy B, Mroz EA, Ross K, Niemierko A, Rocco JW, et al. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:3621-3627 10.1200/jco.2015.62.2126
Omega-3-Acid Ethyl Esters Block the Protumorigenic Effects of Obesity in Mouse Models of Postmenopausal Basal-like and Claudin-Low Breast Cancer Cite
Ford NA, Rossi EL, Barnett K, Yang P, Bowers LW, Hidaka BH, et al. Omega-3-Acid Ethyl Esters Block the Protumorigenic Effects of Obesity in Mouse Models of Postmenopausal Basal-like and Claudin-Low Breast Cancer. Cancer Prevention Research. American Association for Cancer Research (AACR); 2015; 8:796-806 10.1158/1940-6207.capr-15-0018
Primary relapse site pattern in women with triple-negative breast cancer Cite
Beca F, Santos R, Vieira D, Zeferino L, Dufloth R, Schmitt F. Primary relapse site pattern in women with triple-negative breast cancer. Pathology - Research and Practice. Elsevier BV; 2014; 210:571-575 10.1016/j.prp.2014.05.011
Modeling vitamin D actions in triple negative/basal-like breast cancer Cite
LaPorta E, Welsh J. Modeling vitamin D actions in triple negative/basal-like breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. Elsevier BV; 2014; 144:65-73 10.1016/j.jsbmb.2013.10.022
The Association Between Breast Cancer Prognostic Indicators and Serum 25-OH Vitamin D Levels Cite
Peppone LJ, Rickles AS, Janelsins MC, Insalaco MR, Skinner KA. The Association Between Breast Cancer Prognostic Indicators and Serum 25-OH Vitamin D Levels. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2012; 19:2590-2599 10.1245/s10434-012-2297-3
Luminal breast cancer metastasis is dependent on estrogen signaling Cite
Ganapathy V, Banach-Petrosky W, Xie W, Kareddula A, Nienhuis H, Miles G, et al. Luminal breast cancer metastasis is dependent on estrogen signaling. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2012; 29:493-509 10.1007/s10585-012-9466-4
Radiation Effects on Development of HER2-Positive Breast Carcinomas Cite
Castiglioni F, Terenziani M, Carcangiu ML, Miliano R, Aiello P, Bertola L, et al. Radiation Effects on Development of HER2-Positive Breast Carcinomas. Clinical Cancer Research. American Association for Cancer Research (AACR); 2007; 13:46-51 10.1158/1078-0432.ccr-06-1490
Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers Cite
Wetterskog D, Lopez-Garcia MA, Lambros MB, A'Hern R, Geyer FC, Milanezi F, et al. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers. The Journal of Pathology. Wiley; 2011; 226:84-96 10.1002/path.2974
Comparison of locoregional recurrence in triple-negative and HER2-positive breast cancer subtype after breast-conserving therapy and modern systemic therapy. Cite
Takita C, Reis IM, Miao F, LaFave KE, Gunaseelan V, Hurley J, et al. Comparison of locoregional recurrence in triple-negative and HER2-positive breast cancer subtype after breast-conserving therapy and modern systemic therapy.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:112-112 10.1200/jco.2011.29.27_suppl.112
Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer Cite
Vargo JA, Beriwal S, Ahrendt GM, Soran A, Johnson RR, McGuire K, et al. Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer. Oncology. S. Karger AG; 2011; 80:341-349 10.1159/000330203
Vitamin D Deficiency is Correlated with Poor Outcomes in Patients with Luminal-type Breast Cancer Cite
Kim HJ, Lee YM, Ko BS, Lee JW, Yu JH, Son BH, et al. Vitamin D Deficiency is Correlated with Poor Outcomes in Patients with Luminal-type Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2010; 18:1830-1836 10.1245/s10434-010-1465-6
Predictive tumor and demographic characteristics by 25-OH vitamin D levels in breast cancers: A comparison with matched controls. Cite
Peppone LJ, Rickles A, Morrow GR, Mohile SG, Sprod L, Janelsins MC, et al. Predictive tumor and demographic characteristics by 25-OH vitamin D levels in breast cancers: A comparison with matched controls.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:e21144-e21144 10.1200/jco.2011.29.15_suppl.e21144
The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells Cite
Menendez . The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells. Oncology Reports. Spandidos Publications; 2010; 25 10.3892/or_00001052
Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study Cite
O'Brien KM, Cole SR, Tse C, Perou CM, Carey LA, Foulkes WD, et al. Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study. Clinical Cancer Research. American Association for Cancer Research (AACR); 2010; 16:6100-6110 10.1158/1078-0432.ccr-10-1533
Presenting Features of Breast Cancer Differ by Molecular Subtype Cite
Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T, et al. Presenting Features of Breast Cancer Differ by Molecular Subtype. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2009; 16:2705-2710 10.1245/s10434-009-0606-2
ER+ PR- breast cancer defines a unique subtype of breast cancer that is driven by growth factor signaling and may be more likely to respond to EGFR targeted therapies Cite
Finn RS, Dering J, Ginther C, Press M, Forbes J, Mackey J, et al. ER+ PR- breast cancer defines a unique subtype of breast cancer that is driven by growth factor signaling and may be more likely to respond to EGFR targeted therapies. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2006; 24:514-514 10.1200/jco.2006.24.18_suppl.514